<DOC>
	<DOCNO>NCT02155530</DOCNO>
	<brief_summary>This study prospective randomize trial evaluate compare quantitative qualitative characteristic neointimal formation high low efficacy statin treatment drug elute stent ( DES ) implantation , patient homogeneous heterogeneous neointimal pattern access Optical Coherence Tomography ( OCT ) . The investigator postulate high efficacy statin could superior effect modification neointimal pattern , compare low efficacy statin . Our main hypothesis Atorvastatin 40mg , high efficacy statin might superior effect modification neointimal pattern evaluate serially follow OCT , compare pravastatin 20mg patient DES implantation .</brief_summary>
	<brief_title>COmparison Modification Neointimal Pattern Assessed Optical Coherence Tomography With High Versus Moderate Efficacy Statin Treatment After Drug Eluting Stent Implantation : COMPASS Trial</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Pravastatin</mesh_term>
	<criteria>Patient â‰¥ 20 year old Patients receive OCT related clinical need end point study Patients receive DES within 1 year OCT evaluation Patients homogenous hetero neointimal pattern OCT Nonstatin user moderate low efficacy statin user Refuse participate Contraindication statin treatment Women current potential childbearing Life expectancy &lt; 1 year High efficacy statin user ( Atorvastatin 80mg Rosuvastatin 20mg )</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>